ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
The FDA authorized emergency use of Capstar and generic Nitenpyram to prevent and treat New World screwworm in dogs and cats nationwide.
Read More
The FDA approved Zanvastro, the first drug to treat Alexander disease by targeting abnormal GFAP buildup in pediatric and adult patients.
Read More
CDC and state officials investigated a 2013 multistate Listeria outbreak linked to Crave Brothers soft-ripened cheeses sold at Whole Foods, leading to a recall.
Read More
The FDA approved Roivant’s Lisraya (brepocitinib), the first oral dual TYK2/JAK1 inhibitor, to treat dermatomyositis in adults.
Read More
GURU INC. recalled Infla-650 herbal supplement after FDA found undeclared drugs acetaminophen, diclofenac, and phenylbutazone in the capsules.
Read More
Pennsylvania reports its first measles deaths in 35 years, with two unvaccinated individuals dying amid a 393-case outbreak in 29 counties.
Read More
The FDA approved LISRAYA (brepocitinib), the first oral TYK2/JAK1 inhibitor for treating adult dermatomyositis, on August 27, 2026.
Read More
The FDA upgraded the recall of 1.6 million Midwest Poultry eggs to Class I due to a multistate Salmonella Enteritidis outbreak in 2026.
Read More
Atrium Health partners with Morehouse School of Medicine, investing over $700 million to build a new hospital and expand healthcare in South and West Atlanta.
Read More
OHSU study finds psilocybin safe and effective for treating mood disorders in over 2,300 users in Oregon’s real-world settings.
Read More